MIRA INFORM REPORT

 

 

Report Date :

24.04.2014

 

IDENTIFICATION DETAILS

 

Name :

SUN MEDICAL TECHNOLOGY RESEARCH CORP

 

 

Registered Office :

2990 Shiga Suwa City Nagano-Pref 392-0012 

 

 

Country :

Japan

 

 

Date of Incorporation :

April 2013

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacturer of Auxiliary Artificial Heart. 

 

 

No of Employees :

50

 

 

RATING & COMMENTS

 

MIRA’s Rating :

NB

 

RATING

STATUS

PROPOSED CREDIT LINE

--

NB

                                       New Business

--

 

Status :

New Business

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 


 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

 

D

 




 

japan ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Prime Minister Shinzo ABE has declared the economy his government's top priority; he has overturned his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus, monetary easing, and structural reform. Japan joined the Trans Pacific Partnership negotiations in 2013, a pact that would open Japan's economy to increased foreign competition and create new export opportunities for Japanese businesses. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2013 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which is exceeding 230% of GDP. To help raise government revenue and reduce public debt, Japan decided in 2013 to gradually increase the consumption tax to a total of 10% by the year 2015. Japan is making progress on ending deflation due to a weaker yen and higher energy costs, but reliance on exports to drive growth and an aging, shrinking population pose other major long-term challenges for the economy.

 

Source : CIA

 

 

 


 

Company name

 

SUN MEDICAL TECHNOLOGY RESEARCH CORP

 

 

REGD NAME

 

KK Sun Medical Gijutsu Kenkyujo

 

 

MAIN OFFICE

 

2990 Shiga Suwa City Nagano-Pref 392-0012 JAPAN

Tel: 0266-54-1900      Fax: 0266-58-6443

 

URL:                 http://www.everheart.co.jp

E-Mail address:            (thru the URL)

 

 

ACTIVITIES  

 

Mfg of auxiliary artificial heart

 

BRANCHES

 

Tokyo

 

OVERSEAS

 

USA

 

 

FACTORIES

 

At the caption address

 


OFFICERS

 

MAKOTO TERAURA, PEWA

Shunichi Yamauchi, ch

Yasuo Seki, dir

                       

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES        FAIRA/SALES   Yen 910 M

PAYMENTSSlow                     CAPITAL           Yen 90 M

TREND UNDETD           WORTH            Yen (-) 40 M                                                     

STARTED         2013                 EMPLOYES      50

 

 

COMMENT

 

MFR OF AUXILIARY ARTIFICIAL HEART.

 

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.

 

 

HIGHLIGHTS

           

The subject company was established originally in 1991 for making auxiliary artificial heart, and in 2013 received the financial aid from Hi-Lex Corporation (See and from then restarted making the artificial heart.  This is a specialized mfr of auxiliary artificial heart.  Clients include universities, laboratories, other.

 

 

FINANCIAL INFORMATION

           

Financials are disclosed only partially, and reported Yen 910 million for Oct/2013 fiscal term.

           

For the current term ending Oct 2014 the net profit is projected at Yen 100 million, on a 20% rise in turnover, to Yen 18,200 million, as the firm says.

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:  Apr 2013

Legal Status:       Limited Company (Kabushiki Kaisha)

Authorized:         7,200 shares

Issued:                1.800 shares

Sum:                   Yen 90 million

Major shareholders (%): Hi-Lex Corp* (90)

No. of shareholders: 3

 

*.. Largest mfr of control-cables for motor vehicles, Hyogo-Pref, founded 1946, listed Tokyo S/E (Second section), capital Yen 5,657 million, sales Yen 164,936 million, operating profit Yen 13,877 million, recurring profit Yen 17,089 million, net profit Yen 10,623 million, total assets Yen 167,825 million, net worth Yen 115,253 million, employees 10,054, pres Makoto Teraura

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Manufactures auxiliary artificial heart & supplies (--100%)

 

Clients: [Mfrs, wholesalers] Tokyo University, Ryukyu University, Sanyu Medical, Mutoh Corp, other 

            No. of accounts: 350

            Domestic areas of activities: Nationwide

 

Suppliers: [Mfrs, wholesalers] Hi-Lex Corporation, other

 

Payment record: Slow

 

Location: Business area in Suwa City, Nagano-Pref.  Office premises at the caption address are owned and maintained satisfactorily.

 

Bank References:

SMBC (Suwa)

Hachijuni Bank (Suwa)

Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

Not yet made available

 


 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.07

UK Pound

1

Rs.102.77

Euro

1

Rs.84.49

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.